MOTS-c
FeaturedA mitochondrial peptide studied for exercise capacity, metabolic health, and insulin sensitivity.
Amylin is a hormone co-secreted with insulin by pancreatic beta cells, playing a role in glucose homeostasis. Researchers investigate its ability to slow gastric emptying, suppress glucagon, and promote satiety.
In the literature, Amylin appears most often in work focused on blood sugar, insulin sensitivity and appetite control. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Because it is catalogued here under powder peptides, Amylin also shows up in discussions of metabolism. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
A mitochondrial peptide studied for exercise capacity, metabolic health, and insulin sensitivity.
A triple-agonist (GLP-1/GIP/glucagon) studied for the strongest weight-loss results in its class.
A GLP-1 receptor agonist extensively studied for appetite suppression, weight loss, and glucose control.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.